Nuclear transport of oligonucleotides in HepG2-cells mediated by protamine sulfate and negatively charged liposomes

被引:23
作者
Welz, C
Neuhuber, W
Schreier, H
Metzler, M
Repp, R
Rascher, W
Fahr, A
机构
[1] Univ Marburg, Dept Pharmaceut & Biopharm, D-35032 Marburg, Germany
[2] Univ Erlangen Nurnberg, Dept Anat, D-8520 Erlangen, Germany
[3] Univ Erlangen Nurnberg, Dept Pediat, D-8520 Erlangen, Germany
关键词
oligonucleotide; protamine sulfate; artificial viral envelope; confocal laser scanning microscopy;
D O I
10.1023/A:1026410612600
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. The aim of this study was to characterize the intracellular fate and nuclear uptake kinetics of oligonucleotides (ON) that were complexed with protamine sulfate (PS) and negatively charged liposomes at different ratios of ON to PS. Methods. Double-fluorescence labelling of ON and liposomal lipid was applied to simultaneously monitor the interaction as well as the individual fate of active agent and carrier upon intracellular delivery using confocal laser scanning microscopy (CLSM). A DNA-analogue of a 68-mer intramolecular double-stranded RNA:DNA-hybridoligo-nucleotide (chimeraplasts) with unmodified phosphate backbone was employed. This construct was condensed with PS and coated with a liposomal formulation (AVE(TM)-3 = artificial viral envelope). Results. PS-ON complexes and AVE(TM)-3-coated complexes with a defined composition were very effective in nuclear transport of ON for a ON:PS charge ratio of 1:3. Nucleus:cytosol fluorescence ratios peaked at about 10 hrs and started to decrease again at 21 hrs. Conclusions. AVE(TM) associates with PS-condensed ON, and this complex is able to be taken up by cells and to deliver ON to the nucleus. PS-ON complexes are released from the liposomal formulation, mainly as an extranuclear enzymatic degradation of the liposomal phospholipids. The results of the kinetic analysis can be used to optimize transfection protocols with ON in HepG2 cells.
引用
收藏
页码:1206 / 1211
页数:6
相关论文
共 26 条
[1]   LIPID-COMPOSITION AND FLUIDITY OF THE HUMAN IMMUNODEFICIENCY VIRUS [J].
ALOIA, RC ;
JENSEN, FC ;
CURTAIN, CC ;
MOBLEY, PW ;
GORDON, LM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (03) :900-904
[2]   INFLUENCE OF BACTERIAL RIBONUCLEIC ACID ON ANIMAL CELLS IN CULTURE .2. PROTAMINE ENHANCEMENT OF RNA INTAKE [J].
AMOS, H ;
KEARNS, KE .
EXPERIMENTAL CELL RESEARCH, 1963, 32 (01) :14-&
[3]  
Ando T, 1973, Mol Biol Biochem Biophys, V12, P1
[4]   ELECTRON-MICROSCOPY AND BIOCHEMICAL-PROPERTIES OF POLYAMINE-COMPACTED DNA [J].
BAEZA, I ;
GARIGLIO, P ;
RANGEL, LM ;
CHAVEZ, P ;
CERVANTES, L ;
ARGUELLO, C ;
WONG, C ;
MONTANEZ, C .
BIOCHEMISTRY, 1987, 26 (20) :6387-6392
[5]  
Bennett R M, 1993, Antisense Res Dev, V3, P235
[6]   ARTIFICIAL VIRAL ENVELOPES CONTAINING RECOMBINANT HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) GP160 [J].
CHANDER, R ;
SCHREIER, H .
LIFE SCIENCES, 1992, 50 (07) :481-489
[7]   Correction of the mutation responsible for sickle cell anemia by an RNA-DNA oligonucleotide [J].
ColeStrauss, A ;
Yoon, KG ;
Xiang, YF ;
Byrne, BC ;
Rice, MC ;
Gryn, J ;
Holloman, WK ;
Kmiec, EB .
SCIENCE, 1996, 273 (5280) :1386-1389
[8]  
GAGNE L, 1998, L LIPOSOME RES, V8, P57
[9]   Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery [J].
Godbey, WT ;
Wu, KK ;
Mikos, AG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (09) :5177-5181
[10]   Pharmaceutical approach to somatic gene therapy [J].
Ledley, FD .
PHARMACEUTICAL RESEARCH, 1996, 13 (11) :1595-1614